• Mashup Score: 6

    The molecular mechanisms governing orderly shutdown and retraction of CD4+ type 1 helper T (TH1) cell responses remain poorly understood. Here we show that complement triggers contraction of TH1 responses by inducing intrinsic expression of the vitamin D (VitD) receptor and the VitD-activating enzyme CYP27B1, permitting T cells to both activate and respond to VitD. VitD then initiated the…

    Tweet Tweets with this article
    • RT @AfzaliBehdad: Our paper on #VitaminD #complement and #Tcells in health and disease (https://t.co/Sfa7AzQGI5) kindly highlighted in @Nat…

  • Mashup Score: 2
    Off the Beaten Pathway - 3 year(s) ago

    Not all pathways lead to success, but selectively blocking a single pathway of the complement cascade may lead to the first approved geographic atrophy therapy

    Tweet Tweets with this article
    • “It may be better to use a sniper rifle to target what's really important, instead of using a bazooka to blow the whole thing up” #OphthoTwitter #Ophthalmology #ClinicalTrial #Pharma #GA #AMD #Complement https://t.co/eqZEw152R7

  • Mashup Score: 4
    FEBS Press - 3 year(s) ago

    Skip to Article Content Skip to Article Information

    Tweet Tweets with this article
    • 6/ #Neisseria and #complement deficiency Complement: innate immune defense vs. Neisseria. Congenital and acquired defects in complement increase risk for invasive Neisseria infections (meningococcal disease / disseminated gonococcal infection) https://t.co/bdro2W6zjT

  • Mashup Score: 3
    Off the Beaten Pathway - 3 year(s) ago

    Not all pathways lead to success, but selectively blocking a single pathway of the complement cascade may lead to the first approved geographic atrophy therapy

    Tweet Tweets with this article
    • Not all pathways lead to success. Peter Kaiser on the clinical trial that may lead to a treatment for geographic atrophy (dry AMD) by blocking a specific immune pathway. #OphthoTwitter #Ophthalmology #ClinicalTrial #Pharma #GA #AMD #Complement https://t.co/eqZEw152R7

  • Mashup Score: 6

    Tuesday, June 8, 2021 7:00 AM – 10:30 AM US PDT 7:00 am Overview of Complement Pathways and Associations with Human DiseaseViviana Ferreira, DVM, PhD, University of Toledo College of Medicine7:45 am The Complosome and Mitochondrial ActivityClaudia Kemper, PhD, National Heart, Lung and Blood Institute8:30 am Local Complement Activation…

    Tweet Tweets with this article
    • Join me and Josh Thurman (@CU_Kidney) as we moderate tomorrow’s @FOCISimmunology session supported by @ComplementSoc and @ACRheum on the new roles of #complement in human disease. Talks by @hskulkarni, Claudia Kemper, Viviana Ferreira, and Claire Harris. https://t.co/67LkaZ8wEO